
Metabolic Research
RetatrutideTriple-agonist GLP-1 / GIP / Glucagon peptide
- Studied for pronounced reductions in body weight in trial subjects
- Investigated for improved glycemic and insulin-sensitivity markers
- Explored for reductions in hepatic fat and cardiometabolic risk factors








